Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PSEN2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Presenilin 2 (PSEN2) is a catalytic subunit of the gamma-secretase complex that cleaves APP to produce amyloid-beta peptides. Mutations in PSEN2 cause familial Alzheimer's disease with later onset (50-70 years) compared to PSEN1 mutations. PSEN2 mutations shift the Abeta42/Abeta40 ratio toward longer, more aggregation-prone peptides. Beyond APP cleavage, PSEN2 processes Notch, ErbB4, and other type I transmembrane proteins. PSEN2 also regulates calcium homeostasis in the endoplasmic reticulum and mitochondria-associated ER membranes (MAMs). PSEN2 is highly expressed in peripheral tissues as well as brain, suggesting systemic roles. The Volga German kindred carrying PSEN2 N141I provided early evidence linking presenilin mutations to familial AD.
No AI portrait yet
| Gene Symbol | PSEN2 |
| Full Name | Presenilin 2 |
| Chromosome | 1q42.13 |
| Protein Type | Aspartyl protease (catalytic subunit) |
| Function | Initial cleavage: APP pre-processed by BACE1 to generate C99 |
| Molecular Weight | 50 kDa |
| Amino Acids | 448 aa |
| Exons | 13 |
| Pathways | Blood-Brain Barrier, Cholesterol, Dysbiosis, Epigenetic, Gut Microbiome |
| UniProt ID | O00287 |
| NCBI Gene ID | 5664 |
| GeneCards | PSEN2 |
| Human Protein Atlas | PSEN2 |
| Associated Diseases | AD, Aging, Als, Alzheimer, Alzheimer Disease |
| Known Drugs/Compounds | rapamycin, RAPAMYCIN |
| Interactions | A2M, ABCA1, ABCA7, AD, AKT, AKT1 |
| KG Connections | 869 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
PSEN2["PSEN2
(Presenilin 2)"]
PSEN1["PSEN1
(Presenilin 1)"]
PEN2["PEN2
(Gamma-secretase
component)"]
MAPT["MAPT
(Tau protein)"]
AmyloidBeta["Amyloid-beta
(Abeta peptide)"]
GammaSecretase["gamma-Secretase
Complex"]
EOAD["Early-onset
Alzheimer's Disease"]
AD["Alzheimer's
Disease"]
Neurodegeneration["Neurodegeneration"]
AmyloidPlaques["Amyloid
Plaques"]
TauTangles["Tau
Tangles"]
A2M["A2M
(Alpha-2-Macroglobulin)"]
DHCR24["DHCR24
(Cholesterol
synthesis)"]
PARP1["PARP1
(DNA repair)"]
CognitiveDecline["Cognitive
Decline"]
Apoptosis["Neuronal
Death"]
PSEN2 -->|"forms"| GammaSecretase
PSEN1 -->|"forms"| GammaSecretase
PEN2 -->|"forms"| GammaSecretase
PSEN2 -->|"regulates"| AmyloidBeta
GammaSecretase -->|"cleaves APP to produce"| AmyloidBeta
PSEN2 -->|"activates"| MAPT
MAPT -->|"forms"| TauTangles
PSEN2 -->|"causes"| EOAD
PSEN2 -->|"causes"| AD
AmyloidBeta -->|"aggregates into"| AmyloidPlaques
AmyloidPlaques -->|"leads to"| Neurodegeneration
TauTangles -->|"leads to"| Neurodegeneration
Neurodegeneration -->|"results in"| CognitiveDecline
Neurodegeneration -->|"results in"| Apoptosis
A2M -->|"interacts with"| PSEN2
DHCR24 -->|"interacts with"| PSEN2
PARP1 -->|"interacts with"| PSEN2
style PSEN2 fill:#006494
style AmyloidBeta fill:#ef5350
style EOAD fill:#5d4400
style AD fill:#5d4400
style Neurodegeneration fill:#ef5350
style AmyloidPlaques fill:#ef5350
style TauTangles fill:#ef5350
style CognitiveDecline fill:#5d4400
style Apoptosis fill:#ef5350
style PSEN1 fill:#4a1a6b
style PEN2 fill:#4a1a6b
style MAPT fill:#4a1a6b
style A2M fill:#1b5e20
style DHCR24 fill:#4a1a6b
style PARP1 fill:#1b5e20| Target | Relation | Type | Str |
|---|---|---|---|
| ad_genetic_risk_loci:PSEN2 | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:PSEN2 | data_in | dataset_row | 0.00 |
| ds-f50762b67605 | provides_data_for | dataset | 1.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Autosomal Dominant Alzheimer's Disease | causes | disease | 0.95 |
| Familial Alzheimer's Disease | causes | disease | 0.95 |
| Alzheimer'S Disease | causes | disease | 0.95 |
| Alzheimer's Disease | risk_factor_for | disease | 0.90 |
| Early-Onset Alzheimer's Disease | causes | disease | 0.90 |
| Γ-SECRETASE COMPLEX | component_of | enzyme | 0.90 |
| Amyloid-β | upregulates | protein | 0.85 |
| APP processing | involved_in | process | 0.80 |
| amyloid production | no change | process | 0.80 |
| APP | associated_with | entity | 0.80 |
| Alzheimer's Disease | causes | disease | 0.80 |
| neural stem cells | regulates | cell_type | 0.80 |
| PSEN1 | associated_with | gene | 0.80 |
| Alzheimer | associated_with | disease | 0.75 |
| EOAD | causes | disease | 0.72 |
| TAU | targets | gene | 0.70 |
| STING | activates | gene | 0.70 |
| SQSTM1 | interacts_with | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| ALZHEIMER | associated_with | gene | 0.70 |
| neurodegeneration | expressed_in | disease | 0.70 |
| Alzheimer's disease | causes | disease | 0.70 |
| amyloid-β | regulates | protein | 0.70 |
| AMYLOID | associated_with | gene | 0.70 |
| PRESENILIN | associated_with | gene | 0.70 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| Dementia | inhibits | disease | 0.65 |
| Alzheimer | causes | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| RAPAMYCIN | targets | drug | 0.65 |
| Alzheimer | degrades | disease | 0.65 |
| Atherosclerosis | degrades | disease | 0.65 |
| Als | degrades | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| ALS | transports | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Dementia | regulates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:PSEN2 | data_in | dataset_row | 0.00 |
| ad_genetic_risk_loci:PSEN2 | data_in | dataset_row | 0.00 |
| ds-f50762b67605 | data_in | dataset | 1.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| APOE | associated_with | gene | 0.90 |
| CRISPR/CAS9 | enables_genetic_modification_of | technology | 0.80 |
| APP | associated_with | gene | 0.74 |
| CDK5 | associated_with | gene | 0.70 |
| APP | transports | gene | 0.70 |
| NOTCH | interacts_with | gene | 0.70 |
| LAMP1 | interacts_with | gene | 0.70 |
| INSULIN SIGNALING | regulates | pathway | 0.70 |
| LRRK2 | interacts_with | gene | 0.70 |
| PSEN1 | biomarker_for | gene | 0.70 |
| PSEN1 | targets | gene | 0.70 |
| MAPT | targets | gene | 0.70 |
| MAPT | interacts_with | gene | 0.70 |
| APP | targets | gene | 0.70 |
| LAMP1 | activates | gene | 0.70 |
| NEURONS | activates | cell_type | 0.70 |
| INSULIN SIGNALING | activates | pathway | 0.70 |
| PLP1 | regulates | gene | 0.70 |
| GRIN2B | regulates | gene | 0.70 |
| GRIN1 | regulates | gene | 0.70 |
| GSK3B | interacts_with | gene | 0.70 |
| IDE | regulates | gene | 0.70 |
| CR1 | regulates | gene | 0.70 |
| CD33 | regulates | gene | 0.70 |
| PSEN1 | associated_with | gene | 0.70 |
| APOE | phosphorylates | entity | 0.70 |
| APOPTOSIS | associated_with | gene | 0.66 |
| NEURODEGENERATION | associated_with | gene | 0.66 |
| APP | activates | gene | 0.66 |
| APP | causes | gene | 0.66 |
| MAPT | activates | gene | 0.66 |
| PSEN1 | degrades | gene | 0.65 |
| PSEN1 | causes | gene | 0.65 |
| HIPPOCAMPUS | regulates | brain_region | 0.65 |
| HIPPOCAMPUS | activates | brain_region | 0.65 |
| PSEN1 | stabilizes | gene | 0.65 |
| MITOPHAGY | treats | phenotype | 0.65 |
| ABCA7 | co_discussed | gene | 0.65 |
| TAU | associated_with | protein | 0.64 |
| LMNA | interacts_with | gene | 0.60 |
| FAS | interacts_with | gene | 0.60 |
| APH1B | interacts_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| AD | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-13 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning PSEN2 in their description or question text
No additional research found